Gregory D. Graff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gregory D. Graff has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
David Zilberman
University of California
9 shared publicationsAlan B Bennett
PIPRA (Public-Sector Intellectual Property Resource for Agriculture), Department of Plant Sciences, University of California, Davis, Davis, California, USA
3 shared publications- Amir Heiman
The Hebrew University of Jerusalem
2 shared publications - David Zilberman
Department of Agricultural and Resource Economics, University of California, Berkeley, California, USA;
2 shared publications Gal Hochman
Department of Agriculture, Food, and Resource Economics; Rutgers University; New Brunswick, NJ USA
2 shared publications- Krishanu Saha
Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, USA
2 shared publications
Latest Publications
- Open Access
- 19 May 2026
- Published by European Open Science in European Journal of Agriculture and Food Sciences
- Vol. 8 (3) , 40-49
Impact of Cowpea-Based Carbohydrate Substitutions on Sensory Attributes and Consumer Perceptions of Wheat Bread Formulations
White wheat bread is familiar, inexpensive, and widely eaten, but it contributes little dietary fiber. Cowpea (Vigna unguiculata) flour offers one way to raise the protein and fiber content of bread without asking consumers to switch to an unfamiliar food. This study examined sensory responses and stated willingness to pay (WTP) for wheat breads containing cowpea flour across five formulation experiments, each with 88-142 participants. The experiments compared wheat bread with breads containing 5% or 10% US raw cowpea flour; untreated 10% breads prepared with Nigerian raw, US raw, or US roasted cowpea flour; 10% US raw cowpea breads made with ascorbic acid (AA), vital wheat gluten (VWG), or AA + VWG; the same 10% flour-source comparison after adding AA + VWG; and high-substitution breads containing 33% cooked Nigerian cowpea flour, with or without sucrose. Cowpea addition increased protein and dietary fiber. At 5% and 10% substitution, overall acceptability and WTP were not different from the wheat control, although appearance scores were slightly lower. In the untreated 10% comparison, Nigerian cowpea bread received higher sensory scores and higher WTP than breads made with US raw or US roasted cowpea flour; those differences were no longer significant after AA + VWG were added. VWG alone reduced sensory scores in the 10% US raw formulation. Breads containing 33% cooked cowpea flour scored lower than wheat bread, and sucrose did not restore equivalence. Across experiments, taste and texture were most closely tied to overall acceptability. Taken together, the results suggest that modest cowpea substitution is a practical enrichment strategy for wheat bread, while higher substitution levels and flour-source effects will need further formulation work.
- 19 May 2026
- Published by European Open Science in European Journal of Agriculture and Food Sciences
- Vol. 8 (3) , 40-49
Open AccessImpact of Cowpea-Based Carbohydrate Substitutions on Sensory Attributes and Consumer Perceptions of Wheat Bread Formulations
White wheat bread is familiar, inexpensive, and widely eaten, but it contributes little dietary fiber. Cowpea (Vigna unguiculata) flour offers one way to raise the protein and fiber content of bread without asking consumers to switch to an unfamiliar food. This study examined sensory responses and stated willingness to pay (WTP) for wheat breads containing cowpea flour across five formulation experiments, each with 88-142 participants. The experiments compared wheat bread with breads containing 5% or 10% US raw cowpea flour; untreated 10% breads prepared with Nigerian raw, US raw, or US roasted cowpea flour; 10% US raw cowpea breads made with ascorbic acid (AA), vital wheat gluten (VWG), or AA + VWG; the same 10% flour-source comparison after adding AA + VWG; and high-substitution breads containing 33% cooked Nigerian cowpea flour, with or without sucrose. Cowpea addition increased protein and dietary fiber. At 5% and 10% substitution, overall acceptability and WTP were not different from the wheat control, although appearance scores were slightly lower. In the untreated 10% comparison, Nigerian cowpea bread received higher sensory scores and higher WTP than breads made with US raw or US roasted cowpea flour; those differences were no longer significant after AA + VWG were added. VWG alone reduced sensory scores in the 10% US raw formulation. Breads containing 33% cooked cowpea flour scored lower than wheat bread, and sucrose did not restore equivalence. Across experiments, taste and texture were most closely tied to overall acceptability. Taken together, the results suggest that modest cowpea substitution is a practical enrichment strategy for wheat bread, while higher substitution levels and flour-source effects will need further formulation work.
- Open Access
- 31 August 2020
- Published by Annual Reviews in Annual Review of Genomics and Human Genetics
- Vol. 21 (1) , 509-534
Models of Technology Transfer for Genome-Editing Technologies
Many of the fundamental inventions of genome editing, including meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR, were first made at universities and patented to encourage commercial development. This gave rise to a diversity of technology transfer models but also conflicts among them. Against a broader historical and policy backdrop of university patenting and special challenges concerning research tools, we review the patent estates of genome editing and the diversity of technology transfer models employed to commercialize them, including deposit in the public domain, open access contracts, material transfer agreements, nonexclusive and exclusive licenses, surrogate licenses, and aggregated licenses. Advantages are found in this diversity, allowing experimentation and competition that we characterize as a federalism model of technology transfer. A notable feature of genome editing has been the rise and success of third-party licensing intermediaries. At the same time, the rapid pace of development of genome-editing technology is likely to erode the importance of patent estates and licensing regimes and may mitigate the effect of overly broad patents, giving rise to new substitutes to effectuate commercialization.
- 31 August 2020
- Published by Annual Reviews in Annual Review of Genomics and Human Genetics
- Vol. 21 (1) , 509-534
Open AccessModels of Technology Transfer for Genome-Editing Technologies
Many of the fundamental inventions of genome editing, including meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR, were first made at universities and patented to encourage commercial development. This gave rise to a diversity of technology transfer models but also conflicts among them. Against a broader historical and policy backdrop of university patenting and special challenges concerning research tools, we review the patent estates of genome editing and the diversity of technology transfer models employed to commercialize them, including deposit in the public domain, open access contracts, material transfer agreements, nonexclusive and exclusive licenses, surrogate licenses, and aggregated licenses. Advantages are found in this diversity, allowing experimentation and competition that we characterize as a federalism model of technology transfer. A notable feature of genome editing has been the rise and success of third-party licensing intermediaries. At the same time, the rapid pace of development of genome-editing technology is likely to erode the importance of patent estates and licensing regimes and may mitigate the effect of overly broad patents, giving rise to new substitutes to effectuate commercialization.
- Open Access
- 25 November 2019
- Published by Wiley in The Journal of World Intellectual Property
- Vol. 23 (1-2) , 40-64
Inventions and patenting in Africa: Empirical trends from 1970 to 2010
Economic development is increasingly dependent upon on utilizing new knowledge to innovate and create value, even in traditional industries and in low‐income countries. This analysis uses evidence on patent families to assess innovation activity throughout sub‐Saharan Africa. We find patent activity in sub‐Saharan Africa—both by African inventors and by foreign inventors—is comparable to similar regions around the world, when conditioned on economic size. Patent filings in Africa have grown, particularly, since the mid‐1990s, but at different rates within different African jurisdictions. Types of technologies being patented in Africa have remained stable over 30 years, with most in pharmaceuticals, chemistry, biotechnology, and engineering. The majority of patent filings in Africa are from Europe, the United States, and other high income countries. Yet, in South Africa, between 15% and 20% of patent filings are by residents of South Africa, and 3% are from other developing and emerging economies. Only a small share of inventions globally are made in sub‐Saharan Africa, but for those inventions that do arise in Africa, foreign filings are made widely outside of Africa.
- 25 November 2019
- Published by Wiley in The Journal of World Intellectual Property
- Vol. 23 (1-2) , 40-64
Open AccessInventions and patenting in Africa: Empirical trends from 1970 to 2010
Economic development is increasingly dependent upon on utilizing new knowledge to innovate and create value, even in traditional industries and in low‐income countries. This analysis uses evidence on patent families to assess innovation activity throughout sub‐Saharan Africa. We find patent activity in sub‐Saharan Africa—both by African inventors and by foreign inventors—is comparable to similar regions around the world, when conditioned on economic size. Patent filings in Africa have grown, particularly, since the mid‐1990s, but at different rates within different African jurisdictions. Types of technologies being patented in Africa have remained stable over 30 years, with most in pharmaceuticals, chemistry, biotechnology, and engineering. The majority of patent filings in Africa are from Europe, the United States, and other high income countries. Yet, in South Africa, between 15% and 20% of patent filings are by residents of South Africa, and 3% are from other developing and emerging economies. Only a small share of inventions globally are made in sub‐Saharan Africa, but for those inventions that do arise in Africa, foreign filings are made widely outside of Africa.
- 3 May 2019
- Published by Springer Nature
- p. 91-116
The Urban Concentration of Innovation and Entrepreneurship in Agricultural and Natural Resource Industries
- 3 May 2019
- Published by Springer Nature
- p. 91-116
The Urban Concentration of Innovation and Entrepreneurship in Agricultural and Natural Resource Industries
- 1 November 2016
- Published by Elsevier in Bioresource Technology
- Vol. 219, 45-52
Techno-economic and Monte Carlo probabilistic analysis of microalgae biofuel production system
- 1 November 2016
- Published by Elsevier in Bioresource Technology
- Vol. 219, 45-52
Techno-economic and Monte Carlo probabilistic analysis of microalgae biofuel production system
- 11 October 2016
- Published by Springer Nature in Nature Biotechnology
- Vol. 34 (10) , 1025-1031
The emerging patent landscape of CRISPR–Cas gene editing technology
- 11 October 2016
- Published by Springer Nature in Nature Biotechnology
- Vol. 34 (10) , 1025-1031
The emerging patent landscape of CRISPR–Cas gene editing technology
- 9 August 2016
- Published by Springer Nature in Nature Biotechnology
- Vol. 34 (8) , 814-821
The rise and fall of innovation in biofuels
- 9 August 2016
- Published by Springer Nature in Nature Biotechnology
- Vol. 34 (8) , 814-821
The rise and fall of innovation in biofuels
- 7 August 2015
- Published by Springer Nature in Nature Biotechnology
- Vol. 33 (8) , 819-823
The emergence of agbiogenerics
- 7 August 2015
- Published by Springer Nature in Nature Biotechnology
- Vol. 33 (8) , 819-823
The emergence of agbiogenerics
- 28 March 2014
- Published by Edward Elgar Publishing
The dynamic IP system in crop genetics and biotechnology
- 28 March 2014
- Published by Edward Elgar Publishing
The dynamic IP system in crop genetics and biotechnology